Brief: Sinopharm Tech Says As Of Jan 18, Bonds In Principal Amount Of HK$89.6 Mln Remained Outstanding For Redemption
18/01/2022 14:11
Jan 18 (Reuters) - Sinopharm Tech Holdings 8156.HK
* AS OF JAN 18, CONVERTIBLE BONDS IN PRINCIPAL AMOUNT OF
HK$89.6
MILLION REMAINED OUTSTANDING FOR REDEMPTION
Source text for Eikon: ID:nHKS6dmZk3
Further company coverage: 8156.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm Tech Holdings
See all newsBrief: Sinopharm Tech Group Expects Loss Of Not More Than HK$1 Million For FY
Brief: Sinopharm Tech's Unit To Dispose 400 Shares In Issued Share Capital Of Ever Development
Brief: Sinopharm Tech Appoints Chiu Sin Nang Kenny As Executive Director
Brief: Sinopharm Tech Announces Possible Delay In Publication Of Annual Results Announcement For Year
Brief: Sinopharm Tech Holdings Proposes Capital Reorganisation